未来一周收益：O、PLTR、QCOM、SJ、AMC、PARA、LCID、RIVN、WBD等

As Wall Street heads in to the first full week of November, a diverse group of companies is set to report financial results. Notable names include Palantir Technologies (PLTR), Realty Income (O), QUALCOMM (QCOM) and Block (SQ).

The tech sector will see reports from companies like Twilio (TWLO), Cloudflare (NET), Datadog (DDOG) and Unity Software (U), while Medical Properties Trust (MPW) and Main Street Capital (MAIN) will represent the real estate sector.

The health sector will see reports from Gilead Sciences (GILD), CVS Health (CVS), Moderna (MRNA), Teva Pharmaceuticals (TEVA) and Viatris (VTRS).

Additionally, energy players like Devon Energy (DVN), Duke Energy (DUK), Energy Transfer LP (ET), Marathon Petroleum (MPC) and Petrobras (PBR) will disclose their results.

Other companies on the docket include Paramount Global (PARA), AMC Entertainment (AMC), Warner Bros. Discovery (WBD), Lucid Group (LCID), Rivian Automotive (RIVN), Cleveland-Cliffs (CLF), Cummins (CMI), Corteva (CTVA), Aurora Cannabis (ACB), Canopy Growth (CGC), DraftKings (DKNG) and Beyond Meat (BYND).

Below is a rundown of major quarterly updates anticipated in the week of November 4–8:

Monday, November 4

Palantir Technologies (PLTR)

Palantir Technologies (PLTR) is set to release its Q3 earnings report after the market closes on Monday, with expectations of 29% EPS growth and a 26% increase in revenue. On a YTD basis, shares of the Denver-based software company have climbed over 142%. Wall Street analysts and Seeking Alpha's Quant Rating system maintain a Hold rating on the stock.

SA contributor Michael Del Monte, who holds a bullish stance on Palantir, sees the company positioned for robust growth in both its government and commercial sectors, with expanding and lengthening customer contracts, particularly through its AIP platform. Del Monte forecasts Q3 2024 revenue of $720M—exceeding company guidance—alongside an adjusted operating margin of $245M and EPS of $0.09. Despite Palantir's high valuation, Del Monte believes its recent inclusion in the S&P 500 and strong market momentum could support elevated valuations over time.

In contrast, contributor Juxtaposed Ideas takes a bearish view, noting that while Palantir has effectively capitalized on the AI chip and SaaS boom—driving high double-digit revenue growth—the stock's current valuation appears overly stretched. They caution that, despite strong multi-year performance obligations and a successful AIP platform, the return potential at current levels may be underwhelming.

• Consensus EPS Estimates: $0.09
• Consensus Revenue Estimates: $703.69M
• Earnings Insight: The stock has beaten revenue expectations in 7 of the past 8 quarters, missing EPS estimates in 2 of those reports.

Also reporting: Realty Income (O), Cleveland-Cliffs (CLF), Illumina (ILMN), Vertex Pharmaceuticals (VRTX), NXP Semiconductors N.V. (NXPI), American International Group (AIG), BioNTech SE (BNTX), Wynn Resorts, Limited (WYNN), Diamondback Energy (FANG), Marriott International (MAR) and more.

Tuesday, November 5

 Lumen Technologies (LUMN)

Lumen Technologies (LUMN) is set to release its Q3 earnings report after market close on Tuesday. Analysts expect a ~12% year-over-year decline in revenue, though loss per share is projected to improve by 6% compared to the same period last year.

Both Wall Street analysts and Seeking Alpha's Quant Rating system have maintained a Hold rating on the stock since July 2024.

Stone Fox Capital, a Seeking Alpha Investing Group Leader, has a more cautious outlook, recommending that investors consider selling Lumen. While the stock saw gains tied to AI network contracts, they believe the excitement is overstated due to limited long-term recurring revenues from these deals. 

• Consensus EPS Estimates: -$0.08
• Consensus Revenue Estimates: $3.21B
• Earnings Insight: The stock has beaten EPS expectations in 4 of the past 8 quarters, revenue estimates in 5 of those reports.

Also reporting: CRISPR Therapeutics AG (CRSP), DuPont (DD), Devon Energy (DVN), Archer-Daniels-Midland Company (ADM), Emerson Electric (EMR), Cummins (CMI), Marathon Petroleum Corporation (MPC), Yum! Brands (YUM) and more.

Wednesday, November 6

CVS Health (CVS)

CVS Health (CVS) is slated to announce its Q3 earnings before the bell on Wednesday. Despite strong past performance, CVS shares have lost around 28% YTD.

Analysts on the sell side maintain a Buy rating, contrasting with Seeking Alpha's quant rating, which currently suggests a Hold.

In recent developments, CVS appointed David Joyner as its new CEO and provided preliminary Q3 financial results that fell short of expectations. The company forecast GAAP EPS between $0.03 and $0.08, with non-GAAP EPS ranging from $1.00 to $1.05, both below the consensus estimate of $1.70. CVS attributed the miss primarily to a $1.1B charge related to its Medicare and Individual Exchange businesses, impacting adjusted EPS by $0.63.

Additionally, a $1.2B restructuring charge tied to store closures and cost-saving initiatives weighed on GAAP earnings, while higher-than-expected medical cost trends have affected Q3’s Medical Benefit Ratio, which could hit 95.2%, including a 220-basis point impact from PDRs.

Following these updates, CVS has withdrawn its prior guidance and is set to provide further details during its Q3 earnings call.

• Consensus EPS Estimates: $1.53
• Consensus Revenue Estimates: $92.68B
• Earnings Insight: CVS Health has beaten EPS estimates consistently in 7 of the past 8 quarters, beating revenue in 6 of those reports.

Also reporting: QUALCOMM (QCOM), Gilead Sciences (GILD), Iron Mountain (IRM), AMC Entertainment Holdings (AMC), Virgin Galactic (SPCE), Teva Pharmaceutical Industries (TEVA), Beyond Meat (BYND), Marathon Oil (MRO), SolarEdge Technologies (SEDG), Arm Holdings (ARM), Novo Nordisk (NVO), Take-Two Interactive Software (TTWO), Lyft (LYFT), American Electric Power Company (AEP) and more.

Thursday, November 7

Lucid Group (LCID)

Lucid Motors (LCID) is scheduled to announce its Q3 earnings after the market closes on Thursday. The company has faced a challenging year, with shares plunging 45% over the past 12 months and nearly 47% since the start of 2024. As a result, analysts have mixed opinions on the stock, with both Wall Street analysts and Seeking Alpha's Quant Rating System leaning towards a Hold rating.

• Consensus EPS Estimates: -$0.31
• Consensus Revenue Estimates: $205.18M
• Earnings Insight: Lucid has driven past EPS expectations three times in the past 8 quarters, beating revenue estimates twice in that timeframe.

Also reporting: Block (SQ), Viatris (VTRS), Moderna (MRNA), Airbnb (ABNB), The Trade Desk (TTD), Pinterest (PINS), DraftKings (DKNG), Unity Software (U), Medical Properties Trust (MPW), Main Street Capital (MAIN), Cloudflare (NET), Novavax (NVAX), Duke Energy (DUK), Halliburton (HAL), Upstart Holdings (UPST), Datadog (DDOG), Petróleo Brasileiro S.A. - Petrobras (PBR), Under Armour (UAA), Rivian Automotive (RIVN), Blink Charging (BLNK), Warner Bros. Discovery (WBD), APA Corporation (APA), Dropbox (DBX), Consolidated Edison (ED), Arista Networks (ANET), Opendoor Technologies (OPEN), Affirm Holdings (AFRM), Sunrun (RUN) and more.

Friday, November 8

Paramount Global (PARA)

Paramount Global (PARA) is gearing to release its Q3 results after the market closes on Thursday, with analysts anticipating an almost 19% Y/Y decline in profits. The New York-based media giant has seen its stock decline by about 26% so far in 2024.

Wall Street analysts remain cautious, giving it a Hold rating, while Seeking Alpha's Quant Rating system upgraded the stock to Strong Buy just a week before the earnings announcement.

• Consensus EPS Estimates: $0.24
• Consensus Revenue Estimates: $6.97B
• Earnings Insight: Paramount Global (PARA) has beaten EPS estimates 5 times and revenue estimates in 2 of the past 8 quarters.

Also reporting: Inovio Pharmaceuticals (INO), MARA Holdings (MARA), Sony Group Corporation (SONY), Baxter International (BAX), Hertz Global Holdings (HTZ) and more.